SCHEMBL24968580

SCHEMBL24968580

CC(C)n1cc(C2CC2)cc(N=C=S)c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24007149 0.81 TAF1 (0.32) —
SCHEMBL24008093 0.75 BMPR1B (0.40) —
SCHEMBL25745854 0.74 BMPR1B (0.38) —
SCHEMBL24007631 0.74 — —
SCHEMBL25745911 0.74 — —
SCHEMBL24566229 0.73 MEN1 (0.31) —
SCHEMBL24008142 0.73 RET (0.32) —
SCHEMBL24007998 0.73 QDPR (0.36) —
SCHEMBL24007996 0.72 — —
SCHEMBL24007158 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265075-A1 6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS AJAX THERAPEUTICS, INC. 2023-08-24 — — US disclosed
WO-2023009712-A1 HETEROARYLOXY THIAZOLO AZINES AS JAK2 INHIBITORS AJAX THERAPEUTICS, INC. (US) 2023-02-02 — — WO disclosed
WO-2023009712-A1 HETEROARYLOXY THIAZOLO AZINES AS JAK2 INHIBITORS AJAX THERAPEUTICS, INC. (US) 2023-02-02 — — WO disclosed
Send feedback